METHOD FOR THE DIAGNOSIS OF ULCERATIVE COLITIS

Patent number:

EP22382873.2

Galicia.svg
No items found.

The present invention belongs to the field of medicine, specifically to the field of diagnosis of ulcerative colitis in a subject with the use of an oligonucleotide probe. The inventors have discovered that a particular Bacteroidetes-associated genotype is present in the gut microbiota of subjects suffering from ulcerative colitis but not in healthy subjects, thus allowing to use the detection of said genotype as an early diagnostic tool. The inventors have also developed a probe for the detection of said genotype.

Countries:
Spain
Regions:
Galicia
Centers:
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, SERVIZO GALEGO DE SAUDE
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

The invention provides a new diagnostic tool for suspected ulcerative colitis. Its implementation in clinical practice would reduce the time to reach the diagnosis. Currently, there isn't a biochemical or genetic marker at the intestinal microbiota level used in routine clinical practice.

Comments

Other related patents

Health

METHOD FOR DIAGNOSING ARTHROSIS

Countries
Spain
Know more
Health

COMPOSITION FOR THE TREATMENT OF THE SIDE EFFECTS OF RADIOTHERAPY AND/OR CHEMOTHERAPY

Countries
Spain
Know more
Health

Combined therapy against cancer

Countries
Spain
Know more
Get back to patents directory